<?xml version='1.0' encoding='UTF-8'?><metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns="http://dublincore.org/documents/dcmi-terms/"><dcterms:title>Effects of Maternal IBD and IBD Breast Milk on Neonatal Gut Microbiome and Intestinal Inflammation</dcterms:title><dcterms:identifier>https://doi.org/10.7939/DVN/10901</dcterms:identifier><dcterms:creator>Huang, Vivian</dcterms:creator><dcterms:creator>Madsen, Karen</dcterms:creator><dcterms:creator>Fedorak, Richard</dcterms:creator><dcterms:creator>Elahi, Shokrollah</dcterms:creator><dcterms:creator>Dieleman, Levinus</dcterms:creator><dcterms:creator>Wine, Eytan</dcterms:creator><dcterms:creator>Agrawal, Ambika</dcterms:creator><dcterms:publisher>UAL Dataverse</dcterms:publisher><dcterms:issued>2016-10-21</dcterms:issued><dcterms:modified>2017-05-26T21:10:21Z</dcterms:modified><dcterms:description>The objective of the study is to compare the intestinal inflammatory response markers of infants born to healthy mothers versus IBD mothers. As well, the fecal microbiome of infants who are breast fed by healthy mothers versus IBD mothers, and  the immunoactive components of breast milk from healthy mothers versus IBD mothers, will be compared.</dcterms:description><dcterms:subject>Medicine, Health and Life Sciences</dcterms:subject><dcterms:subject>Crohn's disease</dcterms:subject><dcterms:subject>pregnancy</dcterms:subject><dcterms:subject>ulcerative colitis</dcterms:subject><dcterms:subject>cohort studies</dcterms:subject><dcterms:subject>infant</dcterms:subject><dcterms:subject>breast milk</dcterms:subject><dcterms:subject>microbiota</dcterms:subject><dcterms:subject>immunology</dcterms:subject><dcterms:subject>inflammatory bowel diseases</dcterms:subject><dcterms:subject>breast feeding</dcterms:subject><dcterms:date>2015</dcterms:date><dcterms:temporal>2015</dcterms:temporal><dcterms:temporal>2017</dcterms:temporal><dcterms:temporal>2015-06</dcterms:temporal><dcterms:temporal>2017</dcterms:temporal><dcterms:relation>Immunological Profiling</dcterms:relation><dcterms:relation>Elevated Fecal Calprotectin in the Second or Third Trimester of Pregnancy Predicts Preterm Delivery in Women with IBD</dcterms:relation><dcterms:type>Clinical data; Biosamples; Questionnaire data</dcterms:type><dcterms:spatial>Alberta</dcterms:spatial><dcterms:spatial>Edmonton</dcterms:spatial><dcterms:spatial>Canada</dcterms:spatial><dcterms:license>NONE</dcterms:license></metadata>